
Bright Minds Biosciences Inc. (DRUG) earnings
- Healthcare
- NASDAQ
- Market cap$201M
Next report
2026-12-22
In 31 daysQ4 FY2026Time not announced· Expected date
- EPS consensus
- -1.07
- Beat streak
- 2
Latest result
96 days ago+87.8%EPS Beat
Estimate recorded after the release
2026-08-17Q3 FY2026
- EPS
- Reported / estimate-0.17 / -1.39
Stock reaction
Unavailable
Recent quarters
Latest 2 quarters| Quarter | EPSReported / estimate | RevenueReported / estimate | Reaction |
|---|---|---|---|
Q3 FY2026 2026-08-17 | -0.17 / -1.39 +87.8%¶ | — / — | Unavailable |
Q2 FY2026 2026-05-20 | -0.80 / -1.06 +24.5%¶ | — / — | Unavailable |
Reported / estimate
- Q3 FY2026 · 2026-08-17UnavailableEPS-0.17 / -1.39+87.8%¶Revenue— / —
- Q2 FY2026 · 2026-05-20UnavailableEPS-0.80 / -1.06+24.5%¶Revenue— / —
- ¶Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.
Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.